Literature DB >> 3722823

Hybridoma production by simplified avidin-mediated electrofusion.

D M Wojchowski, A J Sytkowski.   

Abstract

A simplified method for producing cell hybrids by avidin-mediated electrofusion has been developed. First, biotin was attached both to immunogen and to the surface of murine myeloma cells using N-hydroxysuccinimidobiotin. Biotinylated immunogen was incubated with splenocytes derived from immunized mice and allowed to bind to surface immunoglobulins of B cells. Using streptavidin, biotinylated myeloma cells then were bridged to those B cells bearing biotinylated immunogen. Selective fusion of bridged cells was accomplished by their limited exposure to high-voltage potentials. A high frequency of hybridomas was obtained all of which secreted high titers of antibodies to a selected model immunogen, keyhole limpet hemocyanin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722823     DOI: 10.1016/0022-1759(86)90073-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  The anti-erythrocyte autoimmune response of NZB mice. Identification of two distinct autoantigens.

Authors:  N A Diiulio; R L Fairchild; M J Caulfield
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

3.  Mechanically facilitated cell-cell electrofusion.

Authors:  M J Jaroszeski; R Gilbert; P G Fallon; R Heller
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

4.  A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.

Authors:  I G Macreadie; L A Castelli; D R Hewish; A Kirkpatrick; A C Ward; A A Azad
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 5.  Hybridoma technology: is it still useful?

Authors:  Jane Zveiter Moraes; Bárbara Hamaguchi; Camila Braggion; Enzo Reina Speciale; Fernanda Beatriz Viana Cesar; Gabriela de Fátima da Silva Soares; Juliana Harumi Osaki; Tauane Mathias Pereira; Rodrigo Barbosa Aguiar
Journal:  Curr Res Immunol       Date:  2021-03-22

6.  Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches.

Authors:  James E Crowe
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

Review 7.  Hybridoma technology: new developments of practical interest.

Authors:  S R Samoilovich; C B Dugan; A J Macario
Journal:  J Immunol Methods       Date:  1987-08-03       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.